AlphaMaven AlphaMaven

Jardine Matheson considers private equity-style fundraising for Asia-Pacific acquisition push

Reported by Traders Union
Nov 19, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Jardine Matheson is considering raising external capital through a private equity-style fund, according to three people familiar with management's thinking, as reported first by the Financial Times.
  • • The group faces capital needs of roughly $7-8 billion to fund three more acquisitions of similar size to the $2.4 billion I-MED deal over four to five years, against an $18 billion listed market capitalisation.
  • • Jardines has recycled $1.4 billion of assets so far this year, about 35% of its target of at least $4 billion by 2030, and guides underlying EPS growth of 3% to 6% for 2026.
  • • The review also covers club deals, bond issuance and additional asset sales, and a possible Hong Kong carried interest tax change is cited as a motivating factor.
Summary
Jardine Matheson is exploring new ways to finance acquisitions as the Hong Kong conglomerate shifts from running its Asian businesses directly toward operating more like an investment group. According to the Financial Times, the company is considering raising external capital in a structure similar to a private equity fund, citing three people familiar with management's thinking. The idea follows the appointment last year of chief executive Lincoln Pan, a former co-head of private equity at PAG, to lead the group's transformation. One person said proposed Hong Kong government reforms widening tax breaks on carried interest are a motivating factor. The plan remains at an early stage and may not materialise, and it is unclear whether any such vehicle would include standard features such as management fees. Jardines told the Financial Times it does not comment on private financing arrangements.

Other options under discussion include club deals, in which multiple investors combine capital for a specific buyout, as well as bond issuance and additional asset sales. The financing review sits within a strategy led by Pan to increase exposure to developed Asia-Pacific markets and reduce the group's heavy weighting toward south-east Asia. In May, Jardines agreed to buy Australian radiology provider I-MED for $2.4 billion from UK private equity firm Permira and other shareholders. In June, Pan said the group is targeting three more acquisitions of roughly similar size over the next four to five years.

This implies capital needs of about $7 billion to $8 billion for a company with a listed market capitalisation of $18 billion and first-half 2026 free cash flow of $700 million. Jardines has said it plans to recycle at least $4 billion by 2030 through disposals of underperforming assets. In its third-quarter operating statement, it said underlying earnings per share are expected to rise 3% to 6% this year and that it has already recycled $1.4 billion, about 35% of the target.

To simplify the portfolio, Jardines has sold some non-controlling stakes, including in Toyota, and has taken full control of subsidiaries such as Mandarin Oriental Hotel Group and Gammon Construction. Pan said in June the group would review assets generating less than 7% a year and target returns of at least 11% on new investments.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Traders Union Jardine Matheson considers private equity-style fundraising for Asia-Pacific acquisition push